Osteoarthritis, Hip
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals with a clinical diagnosis of unilateral or bilateral hip osteoarthritis according to at least one of the criteria established by the American College of Rheumatology: hip pain, internal rotation less than 15º and flexion less than 115º; sedentary; both sexes; age between 25 and 70 years; patients will be classified according to the severity of osteoarthritis according to radiographic findings of hip osteoarthritis by the Kellgren and Lawrence Osteoarthritis Classification
Exclusion criteria
Exclusion criteria: Individuals with total or partial hip and/or knee arthroplasty; patients on the waiting list for hip arthroplasty surgery; morbid obesity; general health status compromised by serious or decompensated systemic diseases; cognitive or neurological impairment; those who already undergo some other type of conservative treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A reduction in the level of pain reported by patients is expected, verified using the Numerical Rating Scale, based on the observation of a variation of 20% in pre- and post-intervention measurements;An increase in the level of self-reported physical function by patients, verified through the Western Ontario and Macmaster Universities Osteoarthritis Index (WOMAC), is expected, based on the observation of a variation of at least 20% in pre- and post-intervention measurements;An increase in the level of performance-based physical function, verified through the Timed Up and Go Test, 6-minute Walk Test, 30-second Sit and Stand Test and 4 Step Stair Climbing Test, is expected, based on the finding of a variation of at least 20% in the pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| An increase in the level of muscular strength of the hip muscles is expected, verified using an isometric dynamometer, based on the observation of a variation of 20% in the pre and post intervention measurements.;An increase in the pressure pain threshold level, verified using an algometer, is expected based on the observation of a variation of 20% in the pre- and post-intervention measurements.;A reduction in the individuals' plasma cytokine levels is expected, verified using kits for quantifying inflammatory proteins (TNF-a and interleukin 6), based on the observation of a variation of 20% in pre- and post-intervention measurements.;A reduction in the level of kinesiophobia of patients is expected, verified using the Tampa Kinesiophobia Scale, based on the observation of a variation of 20% in the pre and post intervention measurements. | — |
Countries
Brazil
Contacts
Universidade Federal de Sergipe